Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected With Helicobacter pylori

American Journal of Clinical Pathology

Volumn 108, Issue 1, 1997, Pages 26-34

  Hibi, Kenichi ^a   Mitomi, Hiroyuki ^a,b   Koizumi, Wasaburo ^a   Tanabe, Satoshi ^a   Saigenji, Katsunori ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cell proliferation; Gastric carcinoma; Gastritis; Helicobacter pylori; Ki67; p53

Indexed keywords

PEPSINOGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; MITOSIS; PRIORITY JOURNAL; STOMACH CARCINOMA; STOMACH MUCOSA;

EID: 0030971766     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/108.1.26     Document Type: Article

References (46)

1. Montes G, Cuello C, Correa P, et al. Sodium intake and gastric cancer. J Cancer Res Clin Oncol. 1985;109:42-45.
2. Inoue M, Tajima K, Hirose K, et al. Life-style and subsite of gastric cancer - joint effect of smoking and drinking habits. Int J Cancer. 1994;56:494-499.
3. Wu-Williams AH, Yu MC, Mack TM. Life-style, workplace, and stomach cancer by subsite in young men of Los Angeles county. Cancer Res. 1990;50:2569-2576.
4. Lehtola J. Family study of gastric carcinoma with special reference of two histological types. Scand J Gastroenterol. 1978;13(suppl 50):11-54.
5. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273-1275.
6. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 1993;341:1359-1362.
7. Endo S, Ohkusa T, Saito Y, et al. Detection of Helicobacter pylori infection in early stage gastric cancer. Cancer. 1995;75:2203-2208.
8. Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 61. Lyon, France: International Agency for Research on Cancer; 1994:177-240.
9. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol. 1991;6:209-222.
10. Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 1986;2:15-17.
11. Tsujii M, Kawano S, Tsuji S, et al. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterol. 1992;102:1881-1888.
12. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori . J Med Microbiol. 1988;26:93-99.
13. Moss SF, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori-associated gastritis. Gut. 1994;35:1567-1570.
14. Davies GR, Collins CE, Banatvala N, Rampton DS. A direct relationship between infective load of Helicobacter pylori and oxygen free radical (OFR) production in antral mucosal biopsies. Gut. 1993;34(suppl 1):S73.
15. Silverman JF, Frable WJ. The use of the Diff-Quik stain in the immediate interpretation of fine-needle aspiration biopsies. Diagn Cytopathol. 1990;6:366-369.
16. Marshall BJ, Warren JR, Francis GJ, et al. Rapid urease test in the management of Campylobacter pyloridis-associatcd gastritis. Am J Gastroenterol 1987;82:200-210.
17. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992;339:893-895.
18. Wagner S, Haruma K, Gladziwa U, et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication. Am J Gastroenterol. 1994;89:1211-1218.
19. Segura DI, Montero C. Histochemical characterization of different types of intestinal metaplasia in gastric mucosa. Cancer. 1983;52:498-503.
20. Craanen ME, Blok P, Dekker W, Tytgat GNJ. Helicobacter pylori and early gastric cancer. Gut. 1994;35:1372-1374.
21. Hattori T. Development of adenocarcinomas in the stomach. Cancer. 1986;57:1528-1534.
22. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol. 1993;6:281-289.
23. Imai T, Kubo T, Watanabe H. Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J Natl Cancer Inst. 1971;47:179-195.
24. Cahill RJ, O'Morain CA. Gastric epithelial cell proliferation. Eur J Cancer Prev. 1994;3(suppl 2):55-60.
25. Cahill RJ, Xia H, Kilgallen C, et al. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci. 1995;40:1627-1631.
26. Lynch DAF, Mapstone NP, Clarke AMT, et al. Cell proliferation in Helicobacter pylori-associated gastritis and the effect of eradication therapy. Gut. 1995;36:346-350.
27. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PWN. Helicobacter pylori increases proliferation of gastric epithelial cells. Gut. 1996;38:19-22.
28. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
29. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature. 1987;32:515-517.
30. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990;17:489-503.
31. Gattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-363.
32. Shimizu T, Usuda N, Yamanda T, Sugenoya A, Iida F. Proliferative activity of human thyroid tumors evaluated by proliferative cell nuclear antigen/cyclin immunohistochemical studies. Cancer. 1993;71:2807-2812.
33. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer. 1996;77:373-380.
34. Barbareschi M, Girlando S, Mauri FM, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol. 1994;102:171-175.
35. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554-3560.
36. Mai UEH, Perez-Perez GI, Wahl LM, et al. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest. 1991;87:894-900.
37. Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene. 1994;9:1767-1773.
38. Imatani A, Sasano H, Yabuki N, et al. In situ analysis of tissue dynamics and p53 expression in human gastric mucosa. J Pathol. 1996;179:39-42.
39. Ranzani GN, Luinetti O, Padovan LS, et al. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev. 1995;4:223-231.
40. Brito MJ, Williams GT, Thompson H, Filipe MI. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut. 1994;35:1697-1700.
41. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science. 1984;226:1097-1099.
42. Uesugi H, Saegusa M, Takano Y, Okayasu I. Different expression of bcl-2 protein in gastric adenoma and carcinoma. Pathol Int. 1996;46:274-280.
43. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer. 1995;75:2209-2213.
44. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer. 1994;73:2900-2904.
45. Saegusa M, Takano Y, Okayasu I. Bcl-2 expression and its association with cell kinetics in gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol. 1995;121:357-363.
46. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 1992;80:879-886.